Gersh B J, Kronmal R A, Schaff H V, Frye R L, Ryan T J, Mock M B, Myers W O, Athearn M W, Gosselin A J, Kaiser G C
N Engl J Med. 1985 Jul 25;313(4):217-24. doi: 10.1056/NEJM198507253130403.
We compared the results of coronary artery bypass surgery with those of medical therapy alone in 1491 nonrandomized patients 65 years of age or older. Cumulative survival at six years (adjusted for major differences in important base-line characteristics) was 79 per cent in the surgical group and 64 per cent in the medical group (P less than 0.0001). At five years, chest pain was absent in 62 per cent of the surgical group and 29 per cent of the medical group (P less than 0.0001). Analysis by the Cox proportional-hazards model suggested an independent beneficial effect of surgery on survival (P less than 0.0001). Patients were divided into risk quartiles on the basis of preoperative predictors of survival identified by the Cox model. Surgical benefit was greatest in "high-risk" patients (those in the two quartiles containing patients with the poorest prognosis). Among 234 "low-risk" patients with mild angina, relatively good ventricular function, and no left main coronary artery disease, there was no survival difference between those treated medically and those treated surgically. We conclude that in specific higher-risk subsets of non-randomized patients 65 years of age or older, coronary bypass surgery appeared to improve survival and symptoms in comparison with medical therapy alone. These conclusions must be tempered by consideration of the limitations of nonrandomized studies, particularly since patients in the two treatment groups differed substantially with regard to important base-line characteristics.
我们比较了1491名65岁及以上非随机分组患者的冠状动脉搭桥手术结果与单纯药物治疗的结果。(针对重要基线特征的主要差异进行调整后)手术组的六年累积生存率为79%,药物治疗组为64%(P<0.0001)。五年时,手术组62%的患者胸痛消失,药物治疗组为29%(P<0.0001)。Cox比例风险模型分析表明手术对生存有独立的有益影响(P<0.0001)。根据Cox模型确定的术前生存预测指标,将患者分为四个风险四分位数。手术获益在“高危”患者(预后最差的两个四分位数中的患者)中最大。在234名患有轻度心绞痛、心室功能相对良好且无左主干冠状动脉疾病的“低危”患者中,药物治疗组和手术治疗组的生存率没有差异。我们得出结论,在65岁及以上非随机患者的特定高风险亚组中,与单纯药物治疗相比,冠状动脉搭桥手术似乎可改善生存和症状。这些结论必须考虑到非随机研究的局限性,特别是因为两个治疗组的患者在重要基线特征方面存在很大差异。